Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine + dexmedetomidine versus ropivacaine wound infiltration after open kidney surgery
IRCT20130304012695N14Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Ropivacaine + dexmedetomidine with Ropivacaine alone (2 arms). Primary endpoint: Postoperative pain intensity. Started Oct 2022; status: completed.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20130304012695N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130304012695N14.